Compare Manulife Financial Corporation (MFC) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manulife Financial Corporation vs UnitedHealth Group Inc — how do they compare? Manulife Financial Corporation trades at $43.94 (market cap $72.78B), while UnitedHealth Group Inc trades at $399.5 (market cap $364.06B). The key difference: UnitedHealth Group Inc is far larger — about 5× Manulife Financial Corporation's market cap, and Manulife Financial Corporation pays the higher dividend (3.11%). Which is the better fit depends on your goals.
| MFC | UNH | |
|---|---|---|
Market Cap | $72.78B | $364.06B |
Sector | Financials | Health |
52-Week High | $44.77 | $436.35 |
52-Week Low | $30.06 | $259.02 |
Enterprise Value | $67.92B | $405.92B |
Dividend Yield | 3.11% | 2.29% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Manulife Financial (MFC) trades at $43.92, up 0.23% with mixed technical signals showing bearish overall momentum but bullish moving averages. The company reported strong Q2 2026 results with 12% core earnings growth and 21% APE sales increase, though valuation remains elevated at P/E 16.53 and P/B 2.17. Revenue grew to $53.01B in 2025 with net income of $5.78B, while operating cash flow reached $32.11B.
MFC presents a balanced outlook with solid Asian growth and AI initiatives driving operational efficiency, but faces premium valuation concerns and mixed technical indicators. Analyst consensus leans bullish with 57% buy ratings and $51.50 target, though execution risks in wealth management and regulatory scrutiny in Hong Kong warrant caution.
UnitedHealth Group (UNH) trades at $399.06, down 0.78% on the day, with a bearish technical signal but strong fundamental support from consistent earnings beats. The company reported Q2 2026 EPS of $6.38, beating expectations of $4.94, and maintains robust cash flow, funding dividends and buybacks. Recent news highlights strategic moves to reduce pediatric prior authorizations, aiming to improve care access and operational efficiency.
Outlook remains positive with an analyst consensus price target of $476.50, implying 19% upside, though regulatory risks from lawsuits and Medicaid fraud allegations pose challenges. The stock's valuation at a P/E of 26.07 is justified by its market leadership and growth in aging demographics, but investors should monitor legal developments and margin pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
